Cytoplasmic dynein 1 1 is a motor complex responsible for the transport of membranous vesicles and different cargo proteins toward the minus ends of microtubules including mitosis, nuclear migration, Golgi and centrosome localization, organelle and viral transport, and axonal transport (1) (2) (3) (4) . It is a large multisubunit assembly (~1.5 MDa) containing two copies each of DYNC1H1 (the heavy chain), DYNC1I (the intermediate chains) DYNC1LI (the light intermediate chains), and two copies of each of three distinct light chain families (1, 5, 6) . The globular heads of the cytoplasmic dynein heavy chains generate the force for microtubule-based motility (7) (8) (9) . The heavy chains dimerize via their N-terminal stalks, and the stalks contain both the light intermediate chain and intermediate chain-binding regions (10, 11) .
The intermediate chains, light intermediate chains, and three pairs of light chains are at the base of the cytoplasmic dynein 1 complex and form its cargo binding domain (2, (12) (13) (14) (15) . The two intermediate chains are essential components of the cytoplasmic dynein complex, serving as platforms that interact with the heavy chains, the three light chain dimers, as well as the p150 subunit of dynactin, a cargo adaptor complex, and other protein cargoes (12, 13, 16, 17) . The C-terminal half of the protein contains seven WD repeats (18, 19) which are presumed to form a beta propeller structure responsible for interacting with the heavy chain (4, 20) . The N-terminus of the intermediate chain is predicted to form a coiled-coil domain with six heptad repeats that may be involved in intra-or inter-chain protein interactions (21) , including the interaction with the p150 subunit of dynactin (12) . The distinct interaction domains for the three light chain families; DYNLL (LC8), DYNLT (Tctex1), and DYNLRB (Roadblock) are also in the N-terminal half of the intermediate chain (22) (23) (24) .
Biochemical analyses showed that cytoplasmic dynein 1 can be fractionated into two complexes, one containing the heavy chains and the light intermediate chains and the second composed of the intermediate chains and three light chain families (25) (26) (27) ), but it is not known how the intermediate chains might interact directly, or if their interaction requires one or more of the light chain families. A role for the LC8 light chain as a molecular glue has been suggested by its presence in complexes unrelated to dynein (3, 28) .
Supporting this hypothesis are the observations that an N-terminal fragment of the intermediate chain becomes more ordered upon binding of the LC8 or Tctex1 light chains (29, 30) . In addition, there are two regions of alternative splicing in the N-terminus of the two intermediate chain genes which generate at least six unique isoforms (1, 12, 21, 31, 32) . While the functional significance of these intermediate chain isoforms is unknown, there is data supporting the hypothesis that the isoforms of the light intermediate chains and isoforms of the light chain families contribute to the specificity of dynein cargo binding, reviewed in (1, 2, 33) . It is known that the two light intermediate chain family members form only homooligomers producing two distinct cytoplasmic dynein complexes in cells (11) . It has been suggested that the two Tctex1 family members also only form homodimers (34) . However, homo-and hetero-dimerization has been observed between the two members of the Roadblock light chain family (35, 36 generated by cloning the coding region into the pET14b expression vector (QIAGEN Inc.). The coding region for mouse roadblock-1 was obtained from expressed sequence tag using the PCR. A GST-tagged version of roadblock was generated by cloning the coding region into the BamHI/XhoI sites of the pGEX4T-1 expression vector (Amersham Biosciences). All constructs were sequenced to confirm gene sequence and correct reading frame. Expression and purification of fusion proteinsBacterial expression of recombinant proteins was carried out using Escherichia coli BL21 (DE3) as the host cells. To express GST-Roadblock-1, or GST, host cells containing the expression plasmid were grown in LB medium at 37 °C to an A 600 of ~0.8. Expression of the fusion proteins were induced by the addition of IPTG, isopropyl-1-thio-β-D-galactopyranoside, to a final concentration of ~0.25 mM. Protein expression continued for ~3 h at 37 °C before harvesting by centrifugation. The fusion proteins were expressed in soluble forms by guest on September 1, 2017 http://www.jbc.org/ Downloaded from and purified using GSH-Sepharose affinity columns (Amersham Biosciences) following the manufacturer's instructions. The purified GST proteins on beads in phosphate-buffered saline (PBS) including various protease inhibitors were directly used for binding assay experiments. Hexahistidine fused intermediate chain 2C truncations were expressed in soluble form and purified using a Ni 2+ -nitrilotriacetic acid affinity column following the procedure described by the manufacturer (Novagen) for proteins under native condition. The 0.5 M imidazole buffer used for elution of the protein from the column was removed by dialysis prior to use. GST pull-down experiments -GST-Roadblock-1 or GST alone (~10 µg each) prebound to GSHSepharose beads were mixed with 293T cell lysates (100 µg of total protein) containing myctagged full-length intermediate chain - Reactions were terminated by addition of gel sample buffer, and the samples were resolved by SDS-PAGE. DSG was dissolved in N,N-dimethylformamide, and the final N,Ndimethylformamide concentration in the crosslinking reaction mixture was 5% (v/v). Crosslinking of the mammalian expressed full-length 2C was performed in a similar manner except that the cross-linking buffer was 20mM Hepes, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, with protease inhibitors. Analytical Gel Filtration Chromatography -The homogeneity of the complexes formed by the truncated forms of intermediate chain 2C was determined by analytical gel filtration chromatography using a Superose 6 column (Amersham Biosciences) which was calibrated with the following standard proteins (Sigma) with diffusion coefficients, D 20,w , (X10 7 ); sweet potato beta-amylase (5.77), bovine serum albumin (6.19), bovine erythrocyte carbonic anhydrase (9.0), horse heart cytochrome C (11.1) from the Handbook of Biochemistry (37 (38) , and to ensure that the analysis would not be complicated by the presence of regions that can be removed by alternative splicing. The co-immunoprecipitation assay was then used to identify the truncations of the intermediate chain that were able to oligomerize. The mapping data are summarized in Figure 2A . A truncation containing only the predicted N-terminal coiled-coil domain, 1-65, did not oligomerize, while the complementary construct, 66-612, did oligomirize. A larger Nterminal truncation construct, 1-150, which includes the minimal p150 binding domain (12), also did not oligomerize. These data indicate that the N-terminal coiled-coil region is not required for oligomerization. An essential role for the seven WD repeat domain in oligomerization was excluded by the observations that truncation constructs 1-250, and 151-250 oligomerize in the co-immunoprecipitation assay.
MATERIALS and METHODS

Plasmids -
We (24) . This region partially overlapped with the first WD repeat. However, it was proposed that a 39-residue fragment, corresponding to amino acid residues 211-250 of intermediate chain 2C, that excluded the portion of the first WD repeat was the actual roadblockbinding domain (24) . We therefore sought to confirm this hypothesis, so as to more precisely define the Roadblock light chain binding region. To accomplish this, we synthesized an intermediate chain 2C construct which contains a deletion of the 39-residue fragment (amino acids 211-250) fused to the myc epitope (∆Robl). Figure 2B demonstrates that this deletion mutant did not bind to the Roadblock light chain. This confirms that the binding site for the Roadblock light chains resides in the stretch of 39 amino acids. As a positive control, it was found that myc-tagged full-length intermediate chain 2C interacted with GST-Roadblock but not with GST alone. Our data, and recent structural data (24, 39) The smallest continuous intermediate chain region that was expressed in cultured cells, and which was competent to oligomerize, was the 151-250 polypeptide. One possible explanation for the failure of 151-211 truncation polypeptide to oligomerize was that it was unable to fold into the proper conformation for oligomerization. Therefore to further investigate the role of this region in dimerization, several constructs with a deletion of this region were synthesized. While we were unable to express a full length construct with a deletion of that region, an N-terminal construct composed of amino acids 1-282, with a deletion of the 151-211 region (∆151-211), was expressed. The ∆151-211 construct was unable to oligomerize in the co-immunoprecipitation assay. As a positive control for this result, it was observed that the 1-282 truncation construct was competent to oligomerize. These data confirm the essential role of the domain defined by amino acids 151-211 in intermediate chain oligomeirzation. We also note that the ∆151-211 construct which is unable to oligomerize contains all three light chain binding domains.
In vitro analysis of the intermediate chain dimerization domain.
Two in vitro approaches were utilized to further analyze the interactions of the truncation polypeptides. The 151-250 polypeptide, which is the smallest polypeptide competent to oligomerize in vivo and the 1-150 polypeptide which does not oligomerize in vivo were tagged with hexahistidine, expressed in bacteria, and purified. The hydrodynamic behavior of these proteins was then characterized by analytical gel filtration chromatography ( Figure  3) .
The dimerization competent 151-250 truncation construct eluted as a single symmetrical peak and no minor peaks were detected. This indicates that this polypeptide exists in a single molecular state in solution. In contrast, the 1-150 truncation protein eluted as multiple small peaks, suggesting the existence of several molecular states. The formation of these multiple molecular states may be due to the non-specific association between monomeric units.
To further characterize the purified 151-250 protein sample, it was treated with an amine selective cross-linking reagent, DSG, with a linking spacer length of 7.72 Å (Figure 4A) , to crosslink lysine residues that possessed the appropriate accessibility and spatial orientation in solution. The high pH of the reaction buffer and low protein concentration ensured the amine selectivity of the cross-linking reaction. The native and crosslinked 151-250 polypeptides were then analyzed by SDS-PAGE and Coomassie blue staining ( Figure 4B) . A higher mass reaction product was found in the lane with the crosslinked sample. This result indicates that the purified protein also self-associates, consistent with the results obtained in the co-immunoprecipitation assay. The elution pattern of the crosslinked 151-250 protein sample was then analyzed by gel filtration chromatography (Figure 3) . The elution profile of the crosslinked protein was similar to that of the uncrosslinked sample, indicating that the crosslinking reagent stabilized an existing conformation, and that it did not generate higher order artifacts.
Since the 151-250 protein oligmerizes in vivo, the elution of the uncrosslinked protein in a single discrete peak suggests a high affinity between the monomers. The slight shift in elution pattern that was observed in the crosslinked protein sample may be the effect of the crosslinking reagent. These results with purified protein further confirm that the light chains are not required for association of the intermediate chains.
It was observed that the uncrosslinked 151-250 truncation polypeptide, which has a calculated mass of ~12.2 kDa, migrates slower than the 20 kDa mass marker protein on SDS-PAGE ( Figure 4B ). Similar differences between mass of N-terminal intermediate chain fragments as estimated by SDS-PAGE and the calculated mass have previously been observed by Barbar and co-workers (30) . They suggested that the anomalous migration was the result of reduced binding of SDS to the negatively charged Nterminal fragments. We also considered the possibility that the increased mass observed in the crosslinked sample represented not the interaction of two 151-250 polypeptides, but rather the increased mass added to the monomer by the addition of the crosslinking reagent to the eight lysines present in the polypeptide. As a control, samples of the 1-150 truncation, which does not oligomerize, with and without added crosslinking reagent, were analyzed by SDS-PAGE. While this polypeptide has nineteen lysines, no higher mass bands were found in the crosslinked sample. This indicates that addition of the crosslinking reagent mass does not significantly change the migration pattern of the polypeptides. These observations are also in agreement with observation that this polypeptide does not oligomerize in the in vivo coimmunoprecipitation assay, and they are consistent with the chromatography elution profile. It is of particular note that the N-terminal 1-150 truncation polypeptide which migrates close to the 30 kDa mass standard protein also runs slower on SDS-PAGE than expected for its calculated mass of 20.7 kDa. Further these data show that the Nterminal hexahistidines do not induce dimerization or oligomerization of the fusion proteins. When the various proteins are resolved on comparable gels were transferred to a sold support and analyzed by immuno-blotting, the major bands in both the truncations 1-150 and the 151-250 sets of lanes, identified with arrow or star were shown to react with antibodies to hexahistidine (data not shown).
While the uncrosslinked truncation polypeptides migrate slower on SDS-PAGE than expected for their calculated molecular weights, the higher mass product found in the crosslinked 151-250 polypeptide sample ( Figure 4B, arrow) , migrates close to the position predicted for the mass of a 151-250 dimer. In agreement with this observation, we found that when lysates of cells expressing myc-tagged full length intermediate chain 2C were treated with the crosslinking reagent, a higher mass product approximately twice that of the intermediate chain was obtained ( Figure 4C ).
Species comparison of the dimerization domain amino acid sequences. The identified dimerization domain is in the middle of the intermediate chain and C-terminal to the alternative splicing sites. Thus it is present in the three alternative splicing isoforms derived from the intermediate chain gene 2.
Since the intermediate chain polypeptides encoded by rat genes Dync1i1 and Dync1i2 are not identical, but do heterodimerize in vivo (Figure 1 Figure 5A ). As would be expected for a region important for dimerization, there is exceptional conservation between the sequences found in the two proteins. Of the C-terminal most forty four amino acids of the two rat proteins all but three are either identical or contain conserved and semi-conserved substitutions. While the N-terminal portion is not as highly conserved, only ten of the remaining Nterminal amino acids are non-conserved. We also compared the cytoplasmic dynein intermediate chain dimerization domain sequences of other vertebrate species.
There was exceptional conservation in the dimerization region, comparable to that observed between the rat gene 1 and gene 2 sequences. We note for example that of the C-terminal thirty five amino acids, nineteen are identical in the ten different sequences, and that there would be eight other identical columns of amino acids in the C-terminus except for amino acid substitutions found in one of the analyzed sequences. When the invertebrate protein sequences are compared, there is significant conservation in the region despite their evolutionary divergence ( Figure 5B ). While there is less conservation in the N-terminal portion of the domain than was observed in the vertebrates, twenty of the C-terminal most amino acids are either identical or conserved.
We particularly note that there is near identity in the C-terminal seven amino acids of the fifteen vertebrate and invertebrate sequences. (20, 24, 26) . Also, the cytoplasmic dynein complex could be dissociated by urea and other chaotrophic agents into two subcomplexes. One complex contained the heavy chains and light intermediate chains, and a second complex was composed of the intermediate chains and the light chains (25, 26 (27) .
DISCUSSION
The in vivo domain mapping experiments presented here clearly demonstrate that an evolutionarily conserved region, defined by residues 151 to 211 of intermediate chain 2C, is necessary for intermediate chain dimerization (Figure 6 ).
An intermediate chain construct lacking this region, ∆151-211 is unable to dimerize in an in vivo co-immunoprecipitation assay, while a construct that is identical except that it contains this region, is competent to dimerize (Figure 2A) . However, when expressed as a single truncation, this 61 amino acid region alone is not competent to dimerize. The simplest explanation of this result is that some neighboring amino acid sequence is required for the 61 residues to obtain the proper conformation. This analysis is supported by the finding that constructs with the addition of either the neighboring Cterminal thirty two amino acids of the roadblock light chain binding region (151-282) or sequence farther C-terminal from the region (∆LC) are competent to dimerize. This interpretation is also similar to the findings of Mok and co-workers (23). They identified a minimal deletion construct if the intermediate chain that would not bind the Tctex1 light chain. However, they also found that a synthetic peptide corresponding to this region was not sufficient to bind to the light chain.
Since the ∆151-211 construct that does not dimerize contains the binding regions for all three light chains, we conclude that the light chain binding regions and thus the light chains themselves are not necessary for intermediate chain dimerization. Supporting this conclusion is the finding that constructs deleted for all three of the light chain binding regions are competent to dimerize. It has been suggested that one or more of the light chains may serve as an intramolecular glue responsible for holding the two intermediate chains together (3, 24, 28 (30,39,48-50) . Furthermore, LC8 is associated with several dimeric proteins including myosin V (51), and it has been shown that a dimeric coiled-coil of the protein Swallow, a transcription factor linked to asymmetric mRNA distribution, becomes more stable upon LC8 binding (28) . Thus, in principle the presence of the light chains would induce an interaction between intermediate chain truncations which contain those light chain binding domains and this should be detected in our co-immunoprecipitation assay. However, it seems likely that in our experiments the high levels of proteins synthesized during over-expression minimizes the contribution of indirect interactions that might be mediated by endogenous proteins such as the light chains. Consistent with this analysis, no Roadblock light chain was found when the co-immunoprecipitates of the 1-282, 151-250, and 151-282 constructs, which contain that light chain binding domain were probed with antibodies to the light chain (data not shown).
While our data strongly demonstrate that none of the light chains are necessary for intermediate chain dimerization Species names and accession numbers of the compared sequences are in Materials and Methods The dimerization region sequences were aligned and analyzed using ClustalW. The symbols at the bottoms of the columns describe the similarity of the amino acid sequences, "*" the residues in the column are identical in all sequences in the alignment; ":" conserved substitutions are found in the column; "." semiconserved substitutions are present; no symbol indicates lack of conservation. 
